2021. Safety and Efficacy of Bivalirudin in Diabetic Acute Coronary Syndrome (ACS) Patients Undergoing Percutaneous Coronary Intervention (PCI). European Journal of Medical and Health Sciences. 3, 2 (Apr. 2021), 93–97. DOI:https://doi.org/10.24018/ejmed.2021.3.2.768.